The German Breast Cancer Study Group (GBSG2) dataset studies the effects of hormone treatment on recurrence-free survival time.
The event of interest is the recurrence of cancer time.
This data frame contains the observations of 686 women:
horTh: hormonal therapy, a factor at two levels (yes and no).
age: age of the patients in years.
menostat: menopausal status, a factor at two levels pre (premenopausal) and post (postmenopausal).
tsize: tumor size (in mm).
tgrade: tumor grade, a ordered factor at levels I < II < III.
W. Sauerbrei and P. Royston (1999). Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials. Journal of the Royal Statistics Society Series A, Volume 162(1), 71–94
M. Schumacher, G. Basert, H. Bojar, K. Huebner, M. Olschewski, W. Sauerbrei, C. Schmoor, C. Beyerle, R.L.A. Neumann and H.F. Rauschecker for the German Breast Cancer Study Group (1994), Randomized 2 × 2 trial evaluating hormonal treatment and the duration of chemotherapy in node- positive breast cancer patients. Journal of Clinical Oncology, 12, 2086–2093